Enhancing Veteran Access to Cutting-Edge Treatments: Launching a T Cell Engager Therapy Administration ProgramSeptember 3, 2025Conference CoverageOncologyImmuno-oncology
A Case Report on Bortezomib-Induced Hypotension: Rare Adverse Effect in Proteasome Inhibitor TherapySeptember 3, 2025Conference CoverageOncologyMultiple MyelomaHematologic MalignanciesImmuno-oncology
Checkpoint Inhibitor-Associated Optic Neuritis: A Rare irAE With Reversible Vision LossSeptember 2, 2025Conference CoverageOncologyImmuno-oncologyNeurology
A Rare Delayed Presentation of Immune-Related Hepatitis in a Patient Treated With PembrolizumabSeptember 2, 2025Conference CoverageOncologyHepatitisLung CancerImmuno-oncology
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6, 2024Immuno-oncologyMixed TopicsOncologyGenitourinary CancerMelanomaLung CancerVaccines
New mRNA Vaccines in Development for Cancer and InfectionsMay 10, 2024COVID-19 UpdatesBreast CancerImmuno-oncologyGenitourinary CancerLung CancerMelanomaMixed Topics
Do Patients Benefit from Cancer Trial Participation?May 8, 2024MelanomaLung CancerBreast CancerGenitourinary CancerImmuno-oncologyAMLMixed Topics
ASCO Releases Vaccination Guidelines for Adults With CancerMarch 28, 2024Immuno-oncologyLung CancerMelanomaMultiple MyelomaMyelodysplastic SyndromeOncology
Extraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024Mixed TopicsMelanomaLung CancerImmuno-oncologyGenitourinary CancerBreast CancerAML
Unleashing Our Immune Response to Quash CancerFebruary 21, 2024Immuno-oncologyMixed TopicsAMLMultiple MyelomaDiversity in MedicineBusiness of MedicineBreast Cancer
What We Have Learned About Combining a Ketogenic Diet and Chemoimmunotherapy: A Case Report and Review of LiteratureAugust 15, 2023OncologyImmuno-oncologyMixed Topics
A Case Series of Rare Immune-Mediated Adverse Reactions at the New Mexico Veterans Affairs Medical CenterAugust 15, 2023Immuno-oncology
